Pyrrobutamine
![]() | |
| Clinical data | |
|---|---|
| ATC code | R06AX08 (WHO) |
| Identifiers | |
| |
| CAS Number |
91-82-7 |
| PubChem (CID) | 5284614 |
| ChemSpider |
4447659 |
| UNII |
VE6KP18S8X |
| ChEMBL |
CHEMBL1697849 |
| ECHA InfoCard | 100.001.911 |
| Chemical and physical data | |
| Formula | C20H22ClN |
| Molar mass | 311.848 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Pyrrobutamine is an antihistamine and anticholinergic.[1]
References
| Aminoalkyl ethers |
|
|---|---|
| Substituted alkylamines | |
| Substituted ethylenediamines |
|
| Phenothiazine derivatives | |
| Piperazine derivatives | |
| Others for systemic use |
|
| For topical use | |
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
This article is issued from Wikipedia - version of the 8/27/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
